[HTML][HTML] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
EMP Steeghs, JM Boer, MA Horstmann - Leukemia, 2018 - nature.com
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës… - …, 2018 - pubmed.ncbi.nlm.nih.gov
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
[HTML][HTML] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës, EMP Steeghs… - Leukemia, 2018 - ncbi.nlm.nih.gov
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Aries, EMP Steeghs… - Leukemia, 2018 - go.gale.com
The prognosis of children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
has improved considerably over the past decades, and nowadays about 80% of the patients …
has improved considerably over the past decades, and nowadays about 80% of the patients …
[PDF][PDF] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës, EMP Steeghs… - Leukemia, 2018 - pure.eur.nl
The prognosis of children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
has improved considerably over the past decades, and nowadays about 80% of the patients …
has improved considerably over the past decades, and nowadays about 80% of the patients …
[PDF][PDF] RAS pathway mutations as predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës, E MP… - Signaling Pathways as …, 2017 - core.ac.uk
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.
IS Jerchel, AQ Hoogkamer, IM Ariës, EMP Steeghs… - Leukemia, 2017 - europepmc.org
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, A Hoogkamer, I Ariës, L Steeghs, JM Boer… - Leukemia, 2018 - repub.eur.nl
RAS pathway mutations have been linked to relapse and chemotherapy resistance in
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However …
[PDF][PDF] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës, EMP Steeghs… - Leukemia, 2018 - core.ac.uk
The prognosis of children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
has improved considerably over the past decades, and nowadays about 80% of the patients …
has improved considerably over the past decades, and nowadays about 80% of the patients …
[PDF][PDF] RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
IS Jerchel, AQ Hoogkamer, IM Ariës, EMP Steeghs… - Leukemia, 2018 - pure.eur.nl
The prognosis of children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
has improved considerably over the past decades, and nowadays about 80% of the patients …
has improved considerably over the past decades, and nowadays about 80% of the patients …